Key result
Persistent post-COVID chest pain affects up to ~77% of patients at three months or longer.
Why the study?
Persistent chest pain after acute COVID-19 is a common symptom with an unclear etiology and challenging management, leaving knowledge gaps regarding its characteristics, causes, and treatments.
Persistent chest pain is a prevalent symptom following COVID-19 infection with various proposed etiologies, highlighting the need for further research into targeted treatments.
Answers are grounded in this paper and cite their sources.
Persistent chest pain merits evaluation in COVID-19 survivors; extends evidence on post-acute symptom burden while leaving optimal management unresolved.
Persistent chest pain (PCP) following acute COVID-19 infection is a commonly reported symptom with an unclear etiology, making its management challenging. This scoping review aims to address the knowledge gap surrounding the characteristics of PCP following COVID-19, its causes, and potential treatments. This is a scoping review of 64 studies, including observational (prospective, retrospective, cross-sectional, case series, and case-control) and one quasi-experimental study, from databases including Embase, PubMed/MEDLINE, Cochrane CENTRAL, Google Scholar, Cochrane Database of Systematic Reviews, and Scopus. Studies on patients with PCP following mild, moderate, and severe COVID-19 infection were included. Studies with patients of any age, with chest pain that persisted following acute COVID-19 disease, irrespective of etiology or duration were included. A total of 35 studies reported PCP symptoms following COVID-19 (0.24%-76.6%) at an average follow-up of 3 months or longer, 12 studies at 1-3 months and 17 studies at less than 1-month follow-up or not specified. PCP was common following mild-severe COVID-19 infection, and etiology was mostly not reported. Fourteen studies proposed potential etiologies including endothelial dysfunction, cardiac ischemia, vasospasm, myocarditis, cardiac arrhythmia, pneumonia, pulmonary embolism, postural tachycardia syndrome, or noted cardiac MRI (cMRI) changes. Evaluation methods included common cardiopulmonary tests, as well as less common tests such as flow-mediated dilatation, cMRI, single-photon emission computed tomography myocardial perfusion imaging, and cardiopulmonary exercise testing. Only one study reported a specific treatment (sulodexide). PCP is a prevalent symptom following COVID-19 infection, with various proposed etiologies. Further research is needed to establish a better understanding of the causes and to develop targeted treatments for PCP following COVID-19.
No takes yet. Share an insight, caveat, or question.
Kubrova et al. (2023) conducted a review in Persistent chest pain following COVID-19 infection. Persistent chest pain following COVID-19 infection is a prevalent symptom, reported in 0.24% to 76.6% of patients across 35 studies at an average follow-up of 3 months or longer.
Synapse has enriched 10 related papers. Consider them for comparative context: